And then this paper by @KidneydrChirag @NavTangri https://t.co/gOapJZEAqd
New2Trip: Use of sodium-glucose cotransporter-2 inhibitors & risk of acute kidney injury in older adults w/ diabetes: population-based cohort study https://t.co/RuCdqVQld1
New2Trip: Use of sodium-glucose cotransporter-2 inhibitors & risk of acute kidney injury in older adults w/ diabetes: population-based cohort study https://t.co/WJ8AEvlpKW
New2Trip: Use of sodium-glucose cotransporter-2 inhibitors & risk of acute kidney injury in older adults w/ diabetes: population-based cohort study https://t.co/RuCdqVQld1
New2Trip: Use of sodium-glucose cotransporter-2 inhibitors & risk of acute kidney injury in older adults w/ diabetes: population-based cohort study https://t.co/RuCdqVQld1
New2Trip: Use of sodium-glucose cotransporter-2 inhibitors & risk of acute kidney injury in older adults w/ diabetes: population-based cohort study https://t.co/RuCdqVQld1
New2Trip: Use of sodium-glucose cotransporter-2 inhibitors & risk of acute kidney injury in older adults w/ diabetes: population-based cohort study https://t.co/RuCdqVQld1
New2Trip: Use of sodium-glucose cotransporter-2 inhibitors & risk of acute kidney injury in older adults w/ diabetes: population-based cohort study https://t.co/WJ8AEvlpKW
New2Trip: Use of sodium-glucose cotransporter-2 inhibitors & risk of acute kidney injury in older adults w/ diabetes: population-based cohort study https://t.co/RuCdqVQld1
New2Trip: Use of sodium-glucose cotransporter-2 inhibitors & risk of acute kidney injury in older adults w/ diabetes: population-based cohort study https://t.co/WJ8AEvlpKW
New2Trip: Use of sodium-glucose cotransporter-2 inhibitors & risk of acute kidney injury in older adults w/ diabetes: population-based cohort study https://t.co/RuCdqVQld1
New2Trip: Use of sodium-glucose cotransporter-2 inhibitors & risk of acute kidney injury in older adults w/ diabetes: population-based cohort study https://t.co/RuCdqVQld1
RT @rincondesisifo: (CMAJ) Uso de iSGLT2 y riesgo de fracaso renal agudo en pac ancianos con DM2 https://t.co/A1gVUsgCBe Est Observ https:/…
RT @rincondesisifo: (CMAJ) Uso de iSGLT2 y riesgo de fracaso renal agudo en pac ancianos con DM2 https://t.co/A1gVUsgCBe Est Observ https:/…
RT @rincondesisifo: (CMAJ) Uso de iSGLT2 y riesgo de fracaso renal agudo en pac ancianos con DM2 https://t.co/A1gVUsgCBe Est Observ https:/…
(CMAJ) Uso de iSGLT2 y riesgo de fracaso renal agudo en pac ancianos con DM2 https://t.co/A1gVUsgCBe Est Observ https://t.co/ytv1heoECE Comentario https://t.co/UdrMBADIZE
SGLT2阻害薬の方がAKIのリスクが低かったという意外な結果に。
【コホート研究】66歳以上の糖尿病患者において、SGLT2阻害薬の新規使用は、DPP-4阻害薬の新規使用と比較して、AKIでの病院受診(救急外来受診や入院)の90日リスク減少と関連した。 https://t.co/XrG5xpMBfN
RT @DanielJDrucker: Real world Use of sodium–glucose cotransporter-2 inhibitors #T2D “Our findings suggest that regulatory warnings about A…
RT @DanielJDrucker: Real world Use of sodium–glucose cotransporter-2 inhibitors #T2D “Our findings suggest that regulatory warnings about A…
Real world Use of sodium–glucose cotransporter-2 inhibitors #T2D “Our findings suggest that regulatory warnings about AKI risk with SGLT2 inhibitors are unwarranted” A population-based cohort study @CMAJ @ICESOntario https://t.co/tXHyED2IdU
RT @RevistaMFSamfyc: Uso de inhibidores de SGLT2 y riesgo de daño renal agudo en personas mayores con diabetes: estudio de cohorte poblacio…
Uso de inhibidores de SGLT2 y riesgo de daño renal agudo en personas mayores con diabetes: estudio de cohorte poblacional https://t.co/tCsf139QFM
RT @drleonjimenez: Señores los glucosuricos NO provocan IRaguda. Por si había dudas. En vida real. https://t.co/G04Dggup5I
RT @drleonjimenez: Señores los glucosuricos NO provocan IRaguda. Por si había dudas. En vida real. https://t.co/G04Dggup5I
Señores los glucosuricos NO provocan IRaguda. Por si había dudas. En vida real. https://t.co/G04Dggup5I
RT @CMAJ: New @ICESOntario study finds SGLT2 inhibitors do not cause acute kidney injury in older adults with diabetes: https://t.co/kQJ4Kt…
Previous warnings about acute #kidney injury (AKI) risk with SGLT2 inhibitors may be unwarranted as new findings by @ICESOntario demonstrate new use of SGLT2 inhibitors compared with use of DPP4 inhibitors was associated with a lower risk of #AKI: https://
RT @CMAJ: New @ICESOntario study finds SGLT2 inhibitors do not cause acute kidney injury in older adults with diabetes: https://t.co/kQJ4Kt…
RT @AndreasLaupacis: New study in @cmaj suggests, like other studies, that regulatory warnings about acute kidney injury risk with SGLT2 i…
RT @CMAJ: New @ICESOntario study finds SGLT2 inhibitors do not cause acute kidney injury in older adults with diabetes: https://t.co/kQJ4Kt…
RT @CMAJ: New @ICESOntario study finds SGLT2 inhibitors do not cause acute kidney injury in older adults with diabetes: https://t.co/kQJ4Kt…
RT @AndreasLaupacis: New study in @cmaj suggests, like other studies, that regulatory warnings about acute kidney injury risk with SGLT2 i…
RT @CMAJ: New @ICESOntario study finds SGLT2 inhibitors do not cause acute kidney injury in older adults with diabetes: https://t.co/kQJ4Kt…
RT @CMAJ: New @ICESOntario study finds SGLT2 inhibitors do not cause acute kidney injury in older adults with diabetes: https://t.co/kQJ4Kt…
New @ICESOntario study finds SGLT2 inhibitors do not cause acute kidney injury in older adults with diabetes: https://t.co/kQJ4KtVN4g https://t.co/nI95SZ5DXl
RT @AndreasLaupacis: New study in @cmaj suggests, like other studies, that regulatory warnings about acute kidney injury risk with SGLT2 i…
RT @AndreasLaupacis: New study in @cmaj suggests, like other studies, that regulatory warnings about acute kidney injury risk with SGLT2 i…
RT @AndreasLaupacis: New study in @cmaj suggests, like other studies, that regulatory warnings about acute kidney injury risk with SGLT2 i…
RT @AndreasLaupacis: New study in @cmaj suggests, like other studies, that regulatory warnings about acute kidney injury risk with SGLT2 i…
New study in @cmaj suggests, like other studies, that regulatory warnings about acute kidney injury risk with SGLT2 inhibitors are unwarranted https://t.co/D9G7gZ5R3E @GregKnoll99 @DavidJuurlink
(cmaj) Uso de iSGLT2 y riesgo de lesión renal aguda en adultos mayores con diabetes: un estudio de cohorte basado en la población En mayores, el uso de inhibidores de SGLT2 en comparación con los iDPP4 se asoció con un menor riesgo de insuf. renal aguda ht